Concepedia

Karin Boslooper

KB

Statistics

Publications

6

Citations

198

H-Index

6

Active since

2008

Affiliations

University Medical Center Groningen(Current)

Medisch Centrum Leeuwarden

Friesland College

's Heeren Loo

University of Groningen

Karin Boslooper is an author at University Medical Center Groningen specializing in oncology, pathology, and medicine.

Top concepts

Publications per year

2008–2017

6

Publications

6

Comorbidity is an independent prognostic factor in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP: a population-based cohort study

André Wieringa, Karin Boslooper, Mels Hoogendoorn et al. · British Journal of Haematology · 2014 · 78 citations

, , +19

Treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone is beneficial but toxic in very elderly patients with diffuse large B-cell lymphoma: a population-based cohort study on treatment, toxicity and outcome

Karin Boslooper, Robby E. Kibbelaar, Huib Storm et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2013 · 50 citations

, , +19

The clinicopathological roles of alpha-B-crystallin and p53 expression in patients with head and neck squamous cell carcinoma

Karin Boslooper, Alfred K. Lam, Jin Gao et al. · Pathology · 2008 · 28 citations · Full text

, , +10

No outcome disparities in patients with diffuse large B-cell lymphoma and a low socioeconomic status

Karin Boslooper, Mels Hoogendoorn, Eric N. van Roon et al. · Cancer Epidemiology · 2017 · 15 citations · Full text

Relapse in stage I(E) diffuse large B‐cell lymphoma

Marcel Nijland, Karin Boslooper, Gustaaf van Imhoff et al. · Hematological Oncology · 2017 · 15 citations · Full text

1–5 of 6